System Transmission

Top Signal

100#1 JOB

Activity

2180Ripe

+936 today

System

Livenow

Terminal Asset View

stockNASDAQ

SLXN

$1.61-3.68%

Silexion Therapeutics Corp

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

17Overripe

Live Analysis Active

Company Mission

Silexion Therapeutics develops experimental medicines for rare and difficult-to-treat diseases. The company works on creating new drugs through scientific research and testing. It makes money by partnering with larger pharmaceutical companies for research funding and hopes to eventually sell approved treatments to patients and healthcare providers.

SLX

Industry Context

Biotechnology companies focus on developing new medical treatments through scientific research. This sector is known for high risk but also high potential rewards when companies successfully develop new drugs. Companies often spend years in research before generating revenue from approved treatments.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

61Matrix

Market Momentum

42.6— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.0x— Normal Volume

Today's Change

-3.68%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing SLXN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:55 PM UTC

As-of 03-15-2026 16:40 UTC

Develops new medicines for rare diseases and makes money by selling these treatments to hospitals and specialty pharmacies.

Price has been trending lower for several months, suggesting investors are cautious about the company's progress showing consolidation pattern.

Biotech sector remains volatile as companies balance high-risk research with potential breakthrough rewards, creating wide price swings, suggesting.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...